Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-100,000
Closed -$1.82M – 6113
2021
Q4
$1.82M Buy
+100,000
New +$2.16M ﹤0.01% 3442

D.E. Shaw & Co's CELL Position: Q4 2023 in Review

D.E. Shaw & Co sold out of PhenomeX (CELL) in Q4 2023, closing a stake of 148,923 shares — an estimated $149K sold.

D.E. Shaw & Co first reported a position in CELL in Q4 2020 and held it in 8 quarters. The position peaked at $2.91M in Q4 2022. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • D.E. Shaw & Co reported no remaining PhenomeX position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 148,923 PhenomeX shares in Q4 2023, an estimated $149K.
  • D.E. Shaw & Co first reported a position in PhenomeX in Q4 2020 and held it in 8 quarters.
  • D.E. Shaw & Co's PhenomeX position peaked at $2.91M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held PhenomeX as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.